The clinical use of potent, well-tolerated, broad-spectrum antibiotics has been paralleled by the development of resistance in bacteria, and the prevalence of highly resistant bacteria in some intensive care units is despairingly commonplace. The intensive care community faces the realistic prospect of untreatable nosocomial infections and should be searching for new approaches to diagnose and manage resistant bacteria. In this review, we discuss some of the relevant underlying biology, with a particular focus on genetic transfer vehicles and the relationship of selection pressure to their movements. It is an attempt to demystify the relevant language and concepts for the anaesthetist and intensivist, to explain some of the reasons for the emergence of resistance in bacteria, and to provide a contextual basis for discussion of management approaches such as selective decontamination and antibiotic cycling.
THE THERAPEUTIC ENVIRONMENT
The intensivist's life would be a lot easier if an ablative approach to all infection solved the problem. However, many factors influence drug susceptibility of and drug delivery to the target organism. The complex nature of fluid shifts 1 and variable drug clearances in the critically ill 2 is a science in itself, and we have learnt to modify therapy to accommodate variable drug penetration and activity 3, 4 . We also know that the species identification and in vitro antibiotic resistance profile generated by the microbiology laboratory is an imperfect predictor of therapeutic outcome, especially in the critically ill. Growth conditions in the intensive care unit (in wounds, abscesses, blood clots, dressings, drains, humidified ventilator tubing, and various catheters) differ significantly from those under which antibiotic susceptibility is tested in the laboratory. Thus, even a complete understanding of the pharmacodynamics and pharmacokinetics of antibiotics is not enough, because the bacterial microflora is itself a dynamic system: bacterial eradication is not assured by optimal administration of an antibiotic against a "sensitive" organism. Bacteria, especially Gram-negative bacteria, sense the environment and can respond appropriately, intercommunicate and co-ordinate group action to mutual advantage. These abilities and their implications are now well understood and will not be further considered here; the reader is referred to readily available reviews [5] [6] [7] [8] . Rather, our purpose is to discuss the unique genetic fluidity of the bacterial microflora, and the consequences of the antibiotic selection pressure we exert upon it.
THE ICU MICROCOSM
The ICU patient is at risk from endogenous infection (from organisms within their own body) as well as exogenous infection (by spread of organisms from staff, the environment, or from other patients), and the relative contribution of each is unclear. There are millions of bacteria in the human bowel for example, and the gut microflora is not well understood. Selective decontamination of the digestive tract (SDD) aims to prevent infection by opportunistic invaders, which either arise from within this microflora or flourish in spite of it 9 . Human health, however, is dependent on these commensal micro-organisms, and disruption of this ecosystem may have dire consequences (such as pseudomembranous colitis). Although often not possible, "targeting" of anti-bacterial or antifungal therapy is usually advised to minimize collateral damage to healthy protective microflora and to prevent development of resistance. In the context of high endemic resistance in staphylococci and other key microorganisms, such as we have in Australia, published SDD protocols are very likely to select multiresistant pathogens and are not generally advised. SDD in critical care is thus viewed with some suspicion, despite apparent recent successes 9, 10 . Nevertheless, advances in bacteriology over the last decade or so inform our debate about antibiotic usage and selection pressure, including strategies such as SDD and antibiotic cycling 11 , and we examine some of these concepts here.
A COMMON BACTERIAL GENE POOL
The idea of a "floating genome" 12 is a concept unique to bacteria, and the movement of genes into (and out of) specialized gene capture systems 13 is a fundamental part of bacterial biology. "Integrons" are systems for the integration, expression, and excision of single (occasionally, double) genes in characteristic "cassettes" 14, 15 , which appear to be ubiquitous among Gram-negative bacteria 16 and illustrate this paradigm nicely. The gene cassette is the smallest common element of a shared bacterial gene pool and capture of these cassettes is an important part of adaptive evolution. In medically important bacteria, these cassettes most commonly encode antibiotic resistance and are often arrayed in groups of two to four genes. The sequential order may vary, and cassettes may move between integrons, even of different class: the integron thus provides a gateway for entire functional genes. This may be within the bac-terial chromosome or within mobile genetic elements such as plasmids, in this way providing both vehicle and mechanism for efficient horizontal gene transfer.
DNA ACQUISITION AND TRANSFER: GENE CAPTURE SYSTEMS AND THE FLOATING GENOME Gene cassettes arrayed within the integron are subject to powerful promotors upstream of the first cassette insertion point, which drive production of the encoded protein (e.g. antibiotic resistance gene), with the most distant gene in the array sometimes expressed weakly or not at all (#3 in Figure 1 ). How resistance genes become cassettes suitable for packaging into an integron is as yet unclear, but probably reflect ancient processes 15 . Subsequent modifications and clonal spread occur by horizontal transfer, as a result of the same selection processes as those operating on the resistance genes themselves [15] [16] [17] .
Several classes of integrons have been described. The presence of Class 1 integrons (the most commonly recognised in medically important bacteria) is positively associated with phenotypic resistance, and the number of gene cassettes documented continues to grow rapidly. The integron commonly carries resistance to drugs which have been used for some time (e.g. sulphas, trimethoprim, aminoglycosides) as well as newer broad-spectrum agents (e.g. antipseudomonal penicillins, carbapenems).
In a study of European nosocomial isolates, a class 1-integron was found in 40% of all Gram-negative bacteria and nearly all multiply resistant isolates 18 
The integron is a widespread bacterial gene capture system. Integrated gene cassettes are excised as circular elements which can be integrated into other arrays. The 59be (filled oval) allows the gene cassette to be integrated (into the integron, by the integrase) and to circularise when excised. seems that most healthy adult Australians carry integrons in their microflora (A. Gestal and H. Stokes, personal communication) and that antibiotic selection actively enriches the microflora for clinically important integron-borne resistance 19 .
DNA TRANSMISSION VEHICLES IN BACTERIA
Naked DNA released from killed bacteria is probably the dominant form of DNA in the intensive care patient on potent broad-spectrum antibiotics, and damaged (broken, or nicked) DNA strands are degraded relatively quickly in wound sites and mucosal surfaces. The "competence" of a bacterium to take up DNA (e.g. DNA fragments from lysed bacteria) is variable, with members of the normal oropharyngeal flora 20 and organisms such as acinetobacter able to directly take up and incorporate DNA into their own genome 21 . Intact circularized DNA (such as in a plasmid) is more resistant to hydrolysis and many medically important plasmids encode their own transfer by "mating" (conjugation), thus completely avoiding exposure to hostile external environments.
Transferable DNA is best protected by formal packaging, such as in a bacteriophage. A bacteriophage is essentially a virus, dependent on the machinery of the host bacteria it parasitizes in order to propagate, sometimes taking and transferring host DNA with it. The DNA in bacteriophages is protected by its viral protein coat, but still requires a viable host bacterium in order to be exchanged or transferred. This process is known as transduction, and varies in detail and specificity (host-range) depending on the receptiveness of different bacteria for the virus/bacteriophage. The host-range may be quite narrow (specific), and the relationship mutually advantageous. There are many examples in which bacteriophages have introduced genetic material which allow the organisms to populate a new niche. To us this appears as "phage-mediated virulence": diphtheria and cholera are examples par excellence 22, 23 .
Plasmids are best viewed as self-replicating DNA circles existing inside the bacterium but separate from the chromosome. Plasmids, unlike viruses (bacteriophages), cannot repackage themselves and move independently into the outside world. They can be found in Gram-negative bacteria from ancient glacial ice 24 and are clearly a fundamental part of bacterial biology. Their host range may be quite variable (from extremely narrow to "broad host-range" plasmids), and they are almost certainly the most important genetic transmission vehicle in the intensive care environment, particularly those capable of self-transfer (by "mating" or "conjugation", as "sexual" or "conjugative" plasmids).
Transposons, as the name implies, are elements which encode their own movement from one position (in a chromosome or plasmid, for example) to another. This movement (transposition) is encoded by the signature enzyme, a transposase. The transposon may also have the ability to transfer from cell to cell, often existing transiently as a plasmid circle (the conjugative transposon), but usually at much lower frequencies than a conjugative plasmid. The term "pathogenicity island" generally refers to a discrete region of chromosomally integrated DNA which is conspicuously different from the rest of the bacterial genomic "backbone" (and therefore presumably acquired as a unit), and which confers specific pathogenicity or virulence attributes. These may be quite large, and often explain important differences between apparently related organisms 25 .
While an oversimplification, it may be helpful to envisage a hierarchy of DNA transmission systems. An integron may capture a gene cassette with a single resistance gene in it. The integron may exist within a plasmid or chromosome, or as part of as a transposon. Indeed, the integron may constitute virtually the entire transposon, and a transposon may in turn exist within a plasmid or a chromosome. The high prevalence and apparent importance of gene cassettes may reflect their role in remodelling, especially of plasmid genomes. While the transfer of large DNA elements between plasmids and chromosomes depends on specific genes (e.g. transposases), the insertion of the smallest element (the individual gene cassette) is catalysed within the integron array by the specific integrase ( Figure 1) .
Genetic transfer events changing bacterial attributes are not biological minutiae: important and well-studied examples include cholera (bacteriophage-mediated virulence and possible transposonmediated serotype change causing the eighth cholera pandemic), diphtheria (bacteriophage-mediated virulence), shigella (virulence plasmid, and phage-determined serotype), plague bacillus (Y. pestis: virulence plasmid/s); enteropathogenic E. coli (pathogenicity islands) and antibiotic resistance in enteric bacteria (plasmids, integrons, transposons). The complex relationships between mobile and fixed components of the bacterial genome are under constant review. Attempts at an integrated oversight are available for those with a working knowledge of bacteriology and molecular biology (e.g. http://aclame.ulb.ac.be/).
SELECTION PRESSURE AND PLANNED VARIATION (ANTIBIOTIC "CYCLING")
Bacteria can therefore be seen as self-maintaining entities with sophisticated survival strategies, which vary in their niche preference and adaptability. They participate in a global gene pool 26 , flux within which is largely a product of selection pressure. The necessity to use appropriate first-line therapy for serious infections such as bacteraemia and ventilator-associated pneumonia [27] [28] [29] combines with the rising tide of resistance to drive increasing empiric use of broadspectrum antibiotics in the critically ill, and there is evidence that this selection pressure operates in clinically relevant ways. Bacterial resistance strategies vary with the bacterium, the drug, and the environment, and so strategies vary in importance from one bacterium to the next. Certain environmentallyadapted bacterial systems are designed to cope with external toxins (e.g. heavy metals) and these may act as antibiotic efflux pumps 30 . They may complement other mechanisms such as antibiotic exclusion, antibiotic target modification and antibiotic destruction. All of these cost a variable amount of energy and may impair other functions or biological balances within the cell. Biological "fitness" of a resistant mutant may therefore be compromised by a given mutation, but this varies with the mechanism involved and may be restored by compensatory mutations over time 31, 32 .
Reduced usage of an antibiotic in the ICU setting has been shown to be associated with reduced resistance to that antibiotic in subsequently cultured isolates over a period of months 33, 34 , and attempts to "cycle" antibiotics to better manage selection for resistance to a given class of antibiotic have met with some success 35, 36 . The key underlying premise of antibiotic cycling is that resistant mutants with reduced biological fitness will be segregated out of the population with reduced selection pressure, although this is clearly not always so 37 . Variations in selection pressure theoretically risk an accumulation of resistance in the microflora, and there remains only cautious acceptance of the principle of antibiotic cycling in the absence of a better understanding of its basis 38, 39 . This is an area which requires more detailed research, before any firm conclusions can be made.
THE HYPERMUTATION STRATEGY
Extreme selection pressure in certain scenarios may even promote the development of highly adaptable populations of mutation-repair defective organisms. The archetype is Pseudomonas aeruginosa infection in the cystic fibrosis patient. In this scenario, there may be a significant population of organisms with mutations in their DNA mismatch-repair system 37, 40 . The presumed biological advantage is that mutative niche adaptation is facilitated. Certainly, the commonest mechanism for carbapenem (and virtually pan-beta lactam-) resistance in this organism is due to mutation events in the aqueous channels (porins) which control antibiotic access to the bacterium, and development of such mutations in vivo is much more common in organisms prone to replication error. Significant biological advantage of such error-prone replication is probably only present in these specific environments.
DIFFERENT RESPONSES TO SELECTION PRESSURE
A final distinction relates to fundamental biological differences between the hardy singleenveloped Gram-positive and the more complex double-enveloped Gram-negative bacteria. It is generally true that Gram-positive organisms such as Staphylococcus aureus are better adapted to survival in the outside world, with better tolerance of drying and longer survival on skin and fomites. Human pathogens among them are more likely to be characterised by a specific toxin or toxins and present a dramatic clinical syndrome in a previously well person (toxic shock syndrome, scarlet fever, etc). Similarly, infection control is more difficult for the hardy Gram-positive agents because of huge environmental and human reservoirs, and they have for many years generated the greatest anxiety 41 . Resistance in the Gram-positive bacteria (e.g. S. aureus, Enterococcus, Pneumococcus spp.) tends to be slowly or incrementally acquired, clonally spread, and phenotypically stable. In the case of vancomycin-resistant enterococci (VRE), the prevalence of phenotypically resistant organisms is a more powerful predictor for subsequent development of resistant infection than the selection pressure that originally drove its development 42 .
Environmentally-adapted Gram-negative pathogens such as Pseudomonas spp. and Acinetobacter spp. share some of the characteristics of the Grampositive agents, their environmental hardiness being attributable at least in part to their reduced permeability (compared to a "typical" Gram-negative, e.g. E. coli). A reduced number of porins in their hydrophobic outer membranes help resist antibiotic penetration, but may be disadvantageous if such impermeability also makes nutrients less available. Importantly then, these organisms also have the ability to acquire new genetic material, achieving high levels of resistance by combining minor decreases in permeability with low levels of enzymatic antibiotic hydrolysis, minimising the "fitness cost". It is therefore easy to see why highly resistant Pseudomonas and Acinetobacter spp. are major emerging threats in the critical care environment.
By contrast, Gram-negative organisms adapted to complex polymicrobial niches in aqueous environments (e.g. enteric bacteria) have greater opportunity to share DNA and generally rely more heavily on their genetic flexibility for biological success. Vibrios (e.g. cholera) frequently carry and exchange discrete genetic elements which may be relatively silent 43 , and conjugal plasmid transfer is a highly efficient method for spreading resistance potential in the enterobacteriaceae (e.g. Klebsiella spp., E. coli). If, as is not uncommonly the case, that resistance potential is encoded by a gene which confers one phenotype in one strain and a different phenotype in another, then it goes unrecognised in surveys of simple resistance profiles in bacteria. We have recently seen a plasmid from a Klebsiella spp. which confers ticarcillin resistancein one strain and complete beta-lactam resistance (including carbapenem resistance) in another, apparently due to antibiotic-selectable outer membrane differences 44 .
One genetic element (e.g. integron, transposon, or plasmid) often encodes multiple resistance genes. Some will be "silent", because of requirements for other factors to express the full phenotype (e.g. membrane permeability differences; Figure 2 ), and some because they are not expressed at all (Figure 1 ). Many will be simply co-inherited (e.g. an ampicillinresistant plasmid which also carries gentamicin resistance). Increasing ability to support critically ill patients in ICU means that coming years may well see the highly resistant Gram-negative pathogen, with its intrinsic genetic flexibility, displace organisms such as MRSA and VRE as the dominant concern.
GOOD HUSBANDRY OF THE MICROFLORA:
A PRESCRIPTION FOR INTENSIVE CARE
A local knowledge of resistance in the microflora is highly valued by clinical decision makers 45 , as the necessity for empiric therapy is well established 46 and the cost of resistance is high 47, 48 . Careful study of the effects of different antibiotic protocols are necessary to determine the consequences of selection pressure in the complex microflora of intensive care. Regular real-time surveillance of the ICU patient microflora is currently feasible, with both culture-based and DNA-based methods (from PCR to DNA microarrays). We need to monitor the phenotype of stable resident flora as well as the resistance potential within the mobile genome, and recognise new potential problem genes as they arrive. Such data could be used to inform prescribers and to measure the impact of relatively uniform antibiotic selection pressure in populations of ICU patients, and even perhaps ultimately in individuals. This should allow us to rationally design antibiotic protocols with a view to antibiotic selection pressure and its consequences.
Detailed decision-making at the bedside with a wide range of decision support tools improves decision accuracy but is not widely adopted, perhaps because of the time cost 48 . However, antibiotic protocols and decision support could reasonably be expected to simplify and improve second-line and thirdline choices in critical sepsis. With drug-resistant outbreaks marked by substantially increased mortality and length of stay 48 , and evidence of novel genes associated with even more serious and highly mobile resistance potential arriving in Australian intensive care units 44 , it should not be hard to justify some fresh approaches.
ROLE OF THE CLINICAL MICROBIOLOGIST
Although detailed local knowledge of antibiotic susceptibilities is valued highly, high-quality data of this type are not widely employed 45 . The clinical microbiologist of the future should ideally provide three key datasets: first, a current description of the common local ICU isolates and their antibiotic resistance phenotypes; second, a rapid detection of organisms in clinical isolates and infection control surveys which justify immediate isolation, or will not respond to standard antibiotic protocols for that Unit; and third, a surveillance system which detects the arrival of new threats in the microflora (e.g. VRE, VRSA, meropenem-resistant Gram-negatives) before they become apparent as clinical isolates. The first is relatively simple and should be a contemporary standard of care, the second requires faster methods such as nucleic-acid detection (PCRs, microarrays etc) which are not yet routinely available, and the third requires an analysis of threat potential which depends on a proper understanding of mobility of genes and selection pressure. A move to nucleic-acid based methods in ICU will enable more meaningful epidemiological studies; it will also allow introduction of routine rapid methods to manage infection control and to identify species and resistance genes in clinical isolates, some methods for which are already established 49 .
CONCLUSION
We strive to treat all infections early, make correct antimicrobial choices, and use the correct dosage and duration. Even so, bacteria will acquire or develop resistance. Horizontal gene transfer is important in the bacterial response to antibiotic selection pressure, and this article provides a basic grounding for some of the arguments about antibiotic resistance and our role as prescribers in its selection. We believe the design of rational antibiotic interventions in critical care will be greatly enhanced by a shift from more traditional views of microbiology to an ecosystems approach. Timely relevant data may be achievable in the near future by complementing conventional bacteriology with rapid culture-independent diagnostics and regular surveillance of the common bacterial gene pool. In the context of empiric antibiotic prescribing in critical sepsis, the proactive ICU physician needs at the bedside an accurate assessment of resistance and virulence potential within the microflora, and a sound understanding of the selection pressures which influence it. specific pathogenic characteristics; are acquired "foreign" DNA, usually integrated into the chromosome (e.g. by 'phage transduction).
Selection pressure: the extent to which conditions favour the evolution of a particular biological variant (e.g. antibiotic selection pressure favouring development of resistant bacteria, by mutation or gene acquisition).
Fitness cost: biological disadvantage consequent upon adaptation under selection pressure (e.g. porin reduction to avoid antibiotic penetration may reduce nutrient access; mutation of a ribosomal subunit to avoid antibiotic effect may reduce efficiency of protein production in the cell); fitness cost may be recovered by subsequent compensatory mutations.
Porins: channels in the hydrophobic outer membrane of Gram-negative bacteria, which permit ingress and egress of aqueous solutes (e.g. nutrients, antibiotics); the main determinants of permeability.
